Equities research analysts forecast that Option Care Health, Inc. (NASDAQ:OPCH – Get Rating) will announce sales of $943.16 million for the current quarter, according to Zacks. Five analysts have provided estimates for Option Care Health’s earnings, with the highest sales estimate coming in at $956.73 million and the lowest estimate coming in at $933.40 million. Option Care Health posted sales of $860.27 million during the same quarter last year, which suggests a positive year-over-year growth rate of 9.6%. The company is expected to issue its next earnings report on Monday, January 1st.
On average, analysts expect that Option Care Health will report full-year sales of $3.85 billion for the current fiscal year, with estimates ranging from $3.82 billion to $3.90 billion. For the next fiscal year, analysts forecast that the company will post sales of $4.18 billion, with estimates ranging from $4.10 billion to $4.27 billion. Zacks’ sales averages are an average based on a survey of sell-side research analysts that cover Option Care Health.
Option Care Health (NASDAQ:OPCH – Get Rating) last announced its quarterly earnings results on Thursday, April 28th. The company reported $0.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.13 by $0.04. Option Care Health had a net margin of 4.81% and a return on equity of 12.53%. The firm had revenue of $915.78 million during the quarter, compared to analysts’ expectations of $839.45 million. During the same period in the prior year, the company posted ($0.02) EPS. The company’s revenue was up 20.6% on a year-over-year basis.
OPCH has been the subject of several recent analyst reports. TheStreet cut shares of Option Care Health from a “b” rating to a “c+” rating in a research report on Thursday, April 28th. Zacks Investment Research cut shares of Option Care Health from a “buy” rating to a “hold” rating in a research report on Tuesday, May 3rd. Barrington Research increased their price objective on shares of Option Care Health from $31.00 to $33.00 in a research report on Friday, April 29th. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on shares of Option Care Health from $32.00 to $39.00 in a research report on Friday, April 29th. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat.com, Option Care Health currently has a consensus rating of “Buy” and a consensus price target of $31.17.
In related news, COO Harriet Booker sold 6,000 shares of the stock in a transaction on Monday, March 7th. The shares were sold at an average price of $26.12, for a total transaction of $156,720.00. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Over the last three months, insiders have sold 18,000 shares of company stock worth $492,660. 0.22% of the stock is owned by insiders.
Several institutional investors have recently added to or reduced their stakes in OPCH. Compagnie Lombard Odier SCmA bought a new position in shares of Option Care Health in the fourth quarter valued at $31,000. Covestor Ltd bought a new position in shares of Option Care Health in the fourth quarter valued at $46,000. US Bancorp DE lifted its stake in shares of Option Care Health by 16.4% in the third quarter. US Bancorp DE now owns 2,843 shares of the company’s stock valued at $69,000 after buying an additional 400 shares in the last quarter. Aristides Capital LLC bought a new position in shares of Option Care Health in the third quarter valued at $201,000. Finally, Sheaff Brock Investment Advisors LLC bought a new position in shares of Option Care Health in the fourth quarter valued at $201,000. 98.23% of the stock is currently owned by hedge funds and other institutional investors.
OPCH opened at $26.47 on Thursday. Option Care Health has a twelve month low of $16.17 and a twelve month high of $30.70. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.16 and a current ratio of 1.59. The business’s fifty day moving average price is $27.78. The firm has a market capitalization of $4.77 billion, a PE ratio of 27.57, a PEG ratio of 1.35 and a beta of 1.27.
About Option Care Health (Get Rating)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Want More Great Investing Ideas?
Receive News & Ratings for Option Care Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Option Care Health and related companies with MarketBeat.com’s FREE daily email newsletter.